These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 34161859)

  • 1. NAD(P)HX dehydratase (NAXD) deficiency due to a novel biallelic missense variant and review of literature.
    Majethia P; Mishra S; Rao LP; Rao R; Shukla A
    Eur J Med Genet; 2021 Sep; 64(9):104266. PubMed ID: 34161859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NAD(P)HX dehydratase (NAXD) deficiency: a novel neurodegenerative disorder exacerbated by febrile illnesses.
    Van Bergen NJ; Guo Y; Rankin J; Paczia N; Becker-Kettern J; Kremer LS; Pyle A; Conrotte JF; Ellaway C; Procopis P; Prelog K; Homfray T; Baptista J; Baple E; Wakeling M; Massey S; Kay DP; Shukla A; Girisha KM; Lewis LES; Santra S; Power R; Daubeney P; Montoya J; Ruiz-Pesini E; Kovacs-Nagy R; Pritsch M; Ahting U; Thorburn DR; Prokisch H; Taylor RW; Christodoulou J; Linster CL; Ellard S; Hakonarson H
    Brain; 2019 Jan; 142(1):50-58. PubMed ID: 30576410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe NAD(P)HX Dehydratase (NAXD) Neurometabolic Syndrome May Present in Adulthood after Mild Head Trauma.
    Van Bergen NJ; Gunanayagam K; Bournazos AM; Walvekar AS; Warmoes MO; Semcesen LN; Lunke S; Bommireddipalli S; Sikora T; Patraskaki M; Jones DL; Garza D; Sebire D; Gooley S; McLean CA; Naidoo P; Rajasekaran M; Stroud DA; Linster CL; Wallis M; Cooper ST; Christodoulou J
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and biochemical distinctions for a metabolite repair disorder caused by NAXD or NAXE deficiency.
    Van Bergen NJ; Walvekar AS; Patraskaki M; Sikora T; Linster CL; Christodoulou J
    J Inherit Metab Dis; 2022 Nov; 45(6):1028-1038. PubMed ID: 35866541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Case with NAD(P)HX Dehydratase (NAXD) Deficiency: A Newly Defined Mutation in a Novel Neurodegenerative Disorder.
    Oz Tuncer G; Randa NC; Aydin S; Aksoy A
    Mol Syndromol; 2022 Jul; 13(4):332-336. PubMed ID: 36158054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel homozygous missense variant in the NAXE gene in an Iranian family with progressive encephalopathy with brain edema and leukoencephalopathy.
    Mohammadi P; Heidari M; Ashrafi MR; Mahdieh N; Garshasbi M
    Acta Neurol Belg; 2022 Oct; 122(5):1201-1210. PubMed ID: 34120322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole exome sequencing in an Indian family links Coats plus syndrome and dextrocardia with a homozygous novel CTC1 and a rare HES7 variation.
    Netravathi M; Kumari R; Kapoor S; Dakle P; Dwivedi MK; Roy SD; Pandey P; Saini J; Ramakrishna A; Navalli D; Satishchandra P; Pal PK; Kumar A; Faruq M
    BMC Med Genet; 2015 Feb; 16():5. PubMed ID: 25928698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NAD(P)HX dehydratase (NAXD) deficiency: a novel neurodegenerative disorder exacerbated by febrile illnesses.
    Zhou J; Li J; Stenton SL; Ren X; Gong S; Fang F; Prokisch H
    Brain; 2020 Feb; 143(2):e8. PubMed ID: 31755961
    [No Abstract]   [Full Text] [Related]  

  • 9. NAXE Mutations Disrupt the Cellular NAD(P)HX Repair System and Cause a Lethal Neurometabolic Disorder of Early Childhood.
    Kremer LS; Danhauser K; Herebian D; Petkovic Ramadža D; Piekutowska-Abramczuk D; Seibt A; Müller-Felber W; Haack TB; Płoski R; Lohmeier K; Schneider D; Klee D; Rokicki D; Mayatepek E; Strom TM; Meitinger T; Klopstock T; Pronicka E; Mayr JA; Baric I; Distelmaier F; Prokisch H
    Am J Hum Genet; 2016 Oct; 99(4):894-902. PubMed ID: 27616477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel biallelic missense mutations in CTC1 gene identified in a Chinese family with Coats plus syndrome.
    Lin H; Gong L; Zhan S; Wang Y; Liu A
    J Neurol Sci; 2017 Nov; 382():142-145. PubMed ID: 29111009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further expanding the mutational spectrum of brain abnormalities, neurodegeneration, and dysosteosclerosis: A rare disorder with neurologic regression and skeletal features.
    Kındış E; Simsek-Kiper PÖ; Koşukcu C; Taşkıran EZ; Göçmen R; Utine E; Haliloğlu G; Boduroğlu K; Alikaşifoğlu M
    Am J Med Genet A; 2021 Jun; 185(6):1888-1896. PubMed ID: 33749994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NAXE deficiency: A neurometabolic disorder of NAD(P)HX repair amenable for metabolic correction.
    Manor J; Calame D; Gijavanekar C; Fisher K; Hunter J; Mizerik E; Bacino C; Scaglia F; Elsea SH
    Mol Genet Metab; 2022 Jun; 136(2):101-110. PubMed ID: 35637064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional analysis of missense DARS2 variants in siblings with leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation.
    Wongkittichote P; Magistrati M; Shimony JS; Smyser CD; Fatemi SA; Fine AS; Bellacchio E; Dallabona C; Shinawi M
    Mol Genet Metab; 2022 Aug; 136(4):260-267. PubMed ID: 35820270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trio exome sequencing identified a novel de novo WASF1 missense variant leading to recurrent site substitution in a Chinese patient with developmental delay, microcephaly, and early-onset seizures: A mutational hotspot p.Trp161 and literature review.
    Zhao A; Zhou R; Gu Q; Liu M; Zhang B; Huang J; Yang B; Yao R; Wang J; Lv H; Wang J; Shen Y; Wang H; Chen X
    Clin Chim Acta; 2021 Dec; 523():10-18. PubMed ID: 34478686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De novo dominant variants affecting the motor domain of KIF1A are a cause of PEHO syndrome.
    Langlois S; Tarailo-Graovac M; Sayson B; Drögemöller B; Swenerton A; Ross CJ; Wasserman WW; van Karnebeek CD
    Eur J Hum Genet; 2016 Jun; 24(6):949-53. PubMed ID: 26486474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous manifestations of NAXD deficiency - A case report.
    Malik MU; Nadir H; Jessop ZM; Cubitt JJ
    Ann Med Surg (Lond); 2020 Dec; 60():352-355. PubMed ID: 33224489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new CUL4B variant associated with a mild phenotype and an exceptional pattern of leukoencephalopathy.
    Weissbach S; Reinert MC; Altmüller J; Krätzner R; Thiele H; Rosenbaum T; Nürnberg P; Gärtner J
    Am J Med Genet A; 2017 Oct; 173(10):2803-2807. PubMed ID: 28817236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel NAXE variants as a cause for neurometabolic disorder: implications for treatment.
    Trinh J; Imhoff S; Dulovic-Mahlow M; Kandaswamy KK; Tadic V; Schäfer J; Dobricic V; Nolte A; Werber M; Rolfs A; Münchau A; Klein C; Lohmann K; Brüggemann N
    J Neurol; 2020 Mar; 267(3):770-782. PubMed ID: 31745726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AARS2 leukoencephalopathy: A new variant of mitochondrial encephalomyopathy.
    Tang Y; Qin Q; Xing Y; Guo D; Di L; Jia J
    Mol Genet Genomic Med; 2019 Apr; 7(4):e00582. PubMed ID: 30706699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanding the phenotypic spectrum of GABRG2 variants: a recurrent GABRG2 missense variant associated with a severe phenotype.
    Zou F; McWalter K; Schmidt L; Decker A; Picker JD; Lincoln S; Sweetser DA; Briere LC; Harini C; ; Marsh E; Medne L; Wang RY; Leydiker K; Mower A; Visser G; Cuppen I; van Gassen KL; van der Smagt J; Yousaf A; Tennison M; Shanmugham A; Butler E; Richard G; McKnight D
    J Neurogenet; 2017; 31(1-2):30-36. PubMed ID: 28460589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.